OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

How Milan’s Youth Project Is Transforming Cancer Care for Young People

Don S. Dizon: Sometimes Home is the Place That Teaches Us How to Leave

Éléonore Caroit։ Gustave Roussy International Egypt Center Becomes a Reference Centre for Oncology Care

LUCERNA Phase 3: Zolbetuximab, Pembrolizumab, and Chemotherapy in CLDN18.2/PD-L1–Positive Gastric/GEJ Cancer

Joshua Brody: The Most Transformational Class of Medicines for Lymphoma Since the Battle Began

Oncology News, Insights, Stories by OncoDaily

Tedros Adhanom Ghebreyesus
Voices

Tedros Adhanom Ghebreyesus: 80 Years Strong - The WHO Constitution

Monica Bertagnolli
Voices

Monica Bertagnolli: Why the National Academy of Medicine Is Needed More Today Than Ever?

Zidesamtinib
Lung Oncology

FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC

Lived Experience Advocacy Hub Research Opportunity: Global Survey on Survivorship

10 Must-Read Posts on Cellular Immunotherapy This Week

CAR-T Therapy: Biology, Mechanisms, Clinical Success, and Future Directions

NIH Launches New Funding Opportunity to Advance AI Research Infrastructure

GLOBOCAN 2024: Looking Beyond the Numbers to Understand Global Cancer Disparities

10 Must-Read Posts In GU Oncology This Week

Miriam Mutebi: The Power of Community Along the Breast Cancer Journey

Voices
Alisse Harris

Alisse Harris: Privileged to Attend My First St. Jude/ALSAC National Training Meeting

Dimitrije Kolovic: Honored to Present My E-Poster on Metastatic Pancreatic Cancer at the ESMO GI 2026

Wafik S. El-Deiry: Looking Forward to the 2026 WIN Symposium on October 2-3

Tedros Adhanom Ghebreyesus: Ghana Strengthens Its Commitment to Health for All

Martha Wanjiru: I Had the Privilege of Mentoring Healthcare Providers at Gikambura Health Centre

Dario Trapani: Rethinking Cytoprotection in Modern Oncology

Adrian Pogacian: Whole-Person Care as a New Concept at the European Women Cancer Assembly

FDA Approvals
Subcutaneous Isatuximab Multiple Myeloma

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Mammo 2026: Global Breast Cancer Virtual Congress

OncoDaily

08 Oct
Mammo 2026

Louisiana Oncology Society 2026 Cancer Congress

Louisiana Oncology Society (LOS)

14 Aug
Louisiana Oncology Society 2026

SIOG 2026 Annual Conference

International Society of Geriatric Oncology (SIOG)

05 Nov
SIOG 2026 Annual Conference

IOS 2026 Best of ASCO

Iowa Oncology Society (IOS)

22 Aug
IOS

The Iowa Cancer Summit 2026

Iowa Cancer Consortium

13 Oct
Iowa Cancer Summit

Immune-oncology
Primary Resistance to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Primary Resistance to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Tumor Microenvironment: Why It Matters for Cancer Immunotherapy

RICE Study: Can Immune Checkpoint Inhibitors Be Used Again After Progression?

KEYNOTE-C93: Pembrolizumab May Replace Chemotherapy in dMMR Endometrial Cancer

NK-Cell Immunotherapy: The Next Frontier in Cancer Treatment

ChemRNA: A New Generation of Simplified RNA Vaccines for Cancer Immunotherapy

10 Must-Read Posts in Immuno-Oncology This Week

Gastrointestinal-Oncology
Myriam Chalabi

Myriam Chalabi: A New Treatment Window for MSS Colon Cancer

FDA Accepts Daraxonrasib NDA for Review in Previously Treated Metastatic Pancreatic Cancer

LUCERNA Phase 3: Zolbetuximab, Pembrolizumab, and Chemotherapy in CLDN18.2/PD-L1–Positive Gastric/GEJ Cancer

ASCOLT Translational Study and Meta-analysis: Adjuvant Aspirin in Molecularly Selected Colorectal Cancer

Targeting the Primary Tumor in Metastatic Pancreatic Cancer 2026

COMPETE Trial: [177Lu]Lu-Edotreotide Prolongs PFS vs Everolimus in Advanced GEP NETs

Three BOT/BAL Studies in Colorectal Cancer and Sarcoma at ESMO Congress 2026

Breast-Oncology
Pregnancy

Pregnancy and Recent Childbirth Do Not Independently Worsen Outcomes in Young Women With Early Breast Cancer

BRCA2 Pathogenic Variants May Identify a Higher-Risk Group in First-Line ER+ Metastatic Breast Cancer

CDK2 Inhibition in CDK4/6 - Resistant Breast Cancer: A New Escape Route Under Study

Gedatolisib Enters ER+ Breast Cancer Care, But the Real Question Is How to Use It

The CDK4/6 Inhibitor Story Is Entering Its Next Chapter in Breast Cancer

High-Risk Node-Negative HR+/HER2− Early Breast Cancer May Carry Recurrence Risk Similar to N1 Disease

Avutometinib Triplet Shows Feasibility After CDK4/6 Inhibitor Progression in HR+/HER2− Metastatic Breast Cancer

Lung-Oncology
Izalontamab Brengitecan

Izalontamab Brengitecan Shows Encouraging Activity in Relapsed ES-SCLC

AdvanTIG-302: Ociperlimab Plus Tislelizumab Does Not Improve Survival in PD-L1–High NSCLC

FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC

Brain-Only Progression in ES-SCLC: When the Brain Progresses, the Systemic Backbone May Still Matter

EGFR Exon 20 and HER2-Deregulated NSCLC: The Rare Lung Cancer Subtypes Moving Into a New Therapeutic Era

EMBER-Lung: A Simple EMR Nudge Nearly Doubled Molecular Testing in Early-Stage NSCLC

Lung Transplant for Lung-Only Stage IV NSCLC: A Bold Idea With Major Caveats

Oncology Tech
Replimune

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

The Thirteen-Minute Infusion: What Sarclisa's Wearable Injector Signals for Cancer Care

Kalshi Launches Sportsbook-Style Markets on Drug Trials and FDA Decisions

After TROP2 and HER2, Is B7-H3 the Next Big ADC Target?

KRAS Grows Up: The Breakthroughs and the Reckonings

Hematology
Leukemia Diagnosis Leukemia symptoms

Leukemia Diagnosis: Every Step From First Symptoms to Treatment and Beyond

Prognostic Scores and Risk Stratification in Myeloproliferative Neoplasms (MPN): 2026 Updates

Chronic Myelomonocytic Leukemia (CMML): Beyond the Overlap, Toward the Bigger Picture

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

ENDURANCE Trial: 2 Years of Lenalidomide Maintenance Matches Continuous Therapy in Standard-Risk Multiple Myeloma

Peripheral T-Cell Lymphomas (PTCL): Another Evolving Lymphoma Story

Europe Opens the Door to Epcoritamab-R² in 2L Follicular Lymphoma: A New Standard?

Radiotherapy
Prostate SBRT

Optimizing Rectal Preparation for Safer Prostate SBRT

Mapping Palliative Radiotherapy Access Across Canada

Early Lung Cancer With ILD: SABR and Surgery Remain Curative Options

MR-Guided Radiotherapy Brings Pain Relief in Metastatic Pancreatic Cancer

GammaTile Redefines Postoperative Radiation for Brain Metastases: Lessons from the Phase III ROADS Trial

Life After Anal Cancer: The Hidden Burden of Chemoradiotherapy

Four-Arc Coplanar VMAT Emerges as a Practical Option for Hippocampal-Sparing Whole-Brain Radiotherapy

OncoDaily TV
World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Rodrigo Sánchez-Bayona open doors

What Makes a Great Oncologist? Insights from Dr. Rodrigo Sánchez-Bayona

Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

ASCO

OncoDaily Highlights from ASCO 2026 Chicago, USA

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Not To Miss
GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

3rd Symposium “Artificial Intelligence in Public Health Research”

2026 IBRI Global Forum on Science, Philanthropy, and Investment

15 Posts Not To Miss From Best of ASCO Africa 2026

Top Growing Medical Universities in Africa: 2026 Edition by BIGR

WHO Calls for Urgent Action as New Cancer Cases Are Projected to Nearly Double by 2050

20 Posts Not To Miss From ESMO GI 2026, Part 2

OncoGrants
Long-term International Fellowship

Conquer Cancer Long-term International Fellowship 2027

CCLG Idea Grant 2026

Bone Cancer Research Trust + CCLG Idea Grant 2026: Advancing Ewing Sarcoma and Osteosarcoma Research

Young Investigator Award 2027

Conquer Cancer Young Investigator Award 2027

Clinical Accelerator Initiative 2026

Lustgarten Foundation Dr. Robert F. Vizza Clinical Accelerator Initiative 2026

Clinical Trials Championship

Breast Cancer Canada and McPeak-Sirois Group Innovative Breast Cancer Clinical Trials Championship 2026

Survivorship Award

Breast Cancer Canada and AstraZeneca Canada Advancing Progress in Survivorship Award 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Chandler Park

Chandler Park

Oncologists Location Louisville, USA
Stephanie Haddad

Stephanie Haddad

Oncologists Location San Antonio, USA
Loizos G. Loizou

Loizos G. Loizou

Oncologists Location Nicosia, Cyprus
Navneet Singh

Navneet Singh

Oncologists Location Chandigarh, India
Wang Xishan

Wang Xishan

Oncologists Location Beijing, China
Shui Yen Soh

Shui Yen Soh

Oncologists Location Singapore, Singapore
Hesham ElGhazaly

Hesham ElGhazaly

Oncologists Location Cairo, Egypt
Thaís Santana

Thaís Santana

Oncologists Location Goiânia, Brazil

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews